Bioorganic and Medicinal Chemistry Letters p. 3700 - 3707 (2018)
Update date:2022-08-04
Topics:
Jin, Le
Zhang, Bin
Hua, Shixian
Ji, Min
Huang, Xiaochao
Huang, Rizhen
Wang, Hengshan
Novel NF-κB inhibitors based on Glycyrrhetinic acid (GA) derivatives containing aminophosphonate ester moieties were rationally designed and synthesized as well as evaluated their antitumor activities using MTT assay. Many target compounds showed potent antitumor activities against the tested human cancer cell lines including cisplatin-resistant cells, and exhibited significant inhibitory activity to the NF-κB with IC50 values at micromolar concentrations in A549 cells, respectively. Among them, compound 12e possessed excellent antitumor activities against the tested human cancer cell lines and showed low cytotoxicity toward to human normal liver cells. Moreover, 12e caused obvious loss of MMP and significantly induced ROS production, and displayed inhibition of cell migration against A549 cells in vitro. Importantly, 12e arrested the cell cycle at the S phases and ultimately induced cell apoptosis in A549 cells through blockage of NF-κB signaling pathway. Our research provided an efficient strategy for targeting NF-κB antitumor drug development.
View Morezhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
Contact:+86-158-05817090
Address:ROOM 9F, FLAT 2, GUODU DEVELOPING BLDG, No.182, ZHAOHUI ROAD
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Contact:0086-29-89196322
Address:North of the Fifth Keji Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
Shandong Yuanli Science and Technology Co., Ltd.
Contact:86-0536-6777557
Address:Zhuliu Industiral Park,Changle County
Doi:10.1021/ja00349a039
(1983)Doi:10.1124/dmd.116.070003
(2016)Doi:10.1021/ic00142a002
(1982)Doi:10.1021/ja01273a065
(1938)Doi:10.1002/jhet.3120
(2018)Doi:10.1016/S0040-4039(00)87345-1
(1982)